These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 18607675
1. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening. Cho HJ, Yu F, Sun R, Lee D, Song MJ. Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675 [Abstract] [Full Text] [Related]
2. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Whitby D, Marshall VA, Bagni RK, Miley WJ, McCloud TG, Hines-Boykin R, Goedert JJ, Conde BA, Nagashima K, Mikovits J, Dittmer DP, Newman DJ. Int J Cancer; 2007 Jan 15; 120(2):321-8. PubMed ID: 17066452 [Abstract] [Full Text] [Related]
5. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Chen J, Ueda K, Sakakibara S, Okuno T, Parravicini C, Corbellino M, Yamanishi K. Proc Natl Acad Sci U S A; 2001 Mar 27; 98(7):4119-24. PubMed ID: 11274437 [Abstract] [Full Text] [Related]
10. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies. Kalt I, Masa SR, Sarid R. Methods Mol Biol; 2009 Mar 27; 471():387-407. PubMed ID: 19109790 [Abstract] [Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? Lazzi S, Bellan C, Amato T, Palummo N, Cardone C, D'Amuri A, De Luca F, Beyanga M, Facchetti F, Tosi P, Leoncini L. Hum Pathol; 2006 Jan 27; 37(1):23-31. PubMed ID: 16360412 [Abstract] [Full Text] [Related]
12. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle. Lacoste V, Nicot C, Gessain A, Valensi F, Gabarre J, Matta H, Chaudhary PM, Mahieux R. Br J Haematol; 2007 Aug 27; 138(4):487-501. PubMed ID: 17659053 [Abstract] [Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. Bihl F, Mosam A, Henry LN, Chisholm JV, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C. AIDS; 2007 Jun 19; 21(10):1245-52. PubMed ID: 17545700 [Abstract] [Full Text] [Related]
15. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus. Cinquina CC, Grogan E, Sun R, Lin SF, Beardsley GP, Miller G. Virology; 2000 Mar 01; 268(1):201-17. PubMed ID: 10683342 [Abstract] [Full Text] [Related]
17. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation. Zhang X, Wang JF, Kunos G, Groopman JE. Cancer Res; 2007 Aug 01; 67(15):7230-7. PubMed ID: 17671191 [Abstract] [Full Text] [Related]
18. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells. Smith CG, Kharkwal H, Wilson DW. J Virol; 2017 Nov 01; 91(21):. PubMed ID: 28835496 [Abstract] [Full Text] [Related]
19. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. Rimessi P, Bonaccorsi A, Stürzl M, Fabris M, Brocca-Cofano E, Caputo A, Melucci-Vigo G, Falchi M, Cafaro A, Cassai E, Ensoli B, Monini P. J Virol; 2001 Aug 01; 75(15):7161-74. PubMed ID: 11435597 [Abstract] [Full Text] [Related]
20. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Katano H, Sato Y, Kurata T, Mori S, Sata T. Virology; 2000 Apr 10; 269(2):335-44. PubMed ID: 10753712 [Abstract] [Full Text] [Related] Page: [Next] [New Search]